Cheetah Medical Inc. Shuffles the C-Suite, Raises $14.5 Million
6/6/2013 9:19:25 AM
More...
|
Cheetah Medical Inc. Appoints Chris Hutchison as President and CEO
6/4/2013 9:44:31 AM
More...
|
New Study in CHEST Validates the Cheetah Medical Inc. NICOM® 100% Non-Invasive Method for Addressing One of the Most Difficult Assessment Issues in Critical Care Medicine
9/5/2012 10:57:42 AM
More...
|
New Study From St. Elizabeth Health Center Trauma Team Demonstrates Value of Cheetah Medical Inc.'s NICOM® Bioreactance® Technology in Level I Trauma Center
8/14/2012 10:51:39 AM
More...
|
Cheetah Medical Inc.'s NICOM(R) Technology Featured in Duke Anesthesiology Study; New Findings of Efficacy to Guide Intraoperative Goal-Directed Fluid Therapy
6/12/2012 9:53:01 AM
More...
|
New Multicenter Study Seeking to Reduce the Devastating Impact of Sepsis Will Rely on Cheetah Medical Inc.'s NICOM(R) Non-Invasive Technology
2/13/2012 10:08:51 AM
More...
|
New Findings Reported by TJ Gan and Authors from Duke Anesthesiology Demonstrate Efficacy of Cheetah Medical Inc.'s NICOM(R) Bioreactance(R) Technology to Guide Goal Directed Intraoperative Therapy
10/17/2011 11:47:29 AM
More...
|
Cheetah Medical Inc. Closes $20 Million Series B Financing
3/15/2010 10:14:25 AM
More...
|
New Multicenter Study Finds That Cardiac Function Measured During Stress Testing With Cheetah Medical Inc.'s BIOREACTANCE(R) Noninvasive Technology Offers New Insights Into Heart Failure
10/2/2009 9:55:16 AM
More...
|
Cheetah Medical Inc.'s BIOREACTANCE(R) Noninvasive Hemodynamic Monitoring Technology Found to Be a Promising Early Diagnostic Tool for Identification of Acute Heart Failure in the Emergency Department
5/18/2009 10:32:58 AM
More...
|
|